Stock Details
FMS is Fresenius Medical Care AG & Co. KGaA's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 28.80$. Average daily volumn in 3 months 565.88k. Market cap 14.72B



Stock symbol : FMS. Exchange : NYSE. Currency : USD
Lastest price : 25.11$. Total volume : 383.59k. Market state PRE
Click reload if you want to check the lastest price on market!!!

Fresenius Medical Care AG & Co. KGaA (FMS)
Last Price
25.11$
Change
0.17
Volume
383.59k

Previous Close24.94
Open24.54
Day Range24.52-25.11
Bid24.65 x 800
Ask24.67 x 1.1k
Volume383.59k
Average Volume565.88k
Market Cap14.72B
Beta0.94
52 Week Range23.29-42.13
Trailing P/E15.79
Foward P/E7.56
Dividend (Yield %)2.82%
Ex-Dividend Date2022-05-13



Financial Details


According to Fresenius Medical Care AG & Co. KGaA's financial reports the company's revenue in 2021 were 17.62B an decrease(0%) over the years 2020 revenue that were of 17.86B. In 2021 the company's total earnings were 969.31M while total earnings in 2020 were 1.16B(-3.1%).


Loading ...



Organization

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the... United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and systems for water treatment; and non-dialysis products, such as acute cardiopulmonary and apheresis products. In addition, it develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. As of February 23, 2022, it operated 4,171 outpatient dialysis clinics in approximately 150 countries. Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Market Cap:
14.72B
Revenue:
17.62B
Total Assets:
34.37B
Total Cash:
1.48B


News about "Fresenius Medical Care AG & Co. KGaA"

Fresenius Medical Care AG & Co. KGaA (ETR:FME) Given a โ‚ฌ64.00 Price Target by Jefferies Financial Group Analysts

Source from : Defense World - 12 hours ago

Jefferies Financial Group set a โ‚ฌ64.00 ($66.67) target price on Fresenius Medical Care AG & Co. KGaA (ETR:FME โ€“ Get Rating) in a research note published on Monday, Borsen Zeitung reports. A number of ...See details»


Fresenius Medical Care AG & Co. KGaA (NYSE: FMS): The Stock For Success Over The Next Few Months

Source from : marketingsentinel - 1 days ago

In the last trading session, 0.38 million Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) shares changed hands as the companyโ€™s beta touched 0. With the companyโ€™s per share price at $25.11 changed ...See details»


fresenius-medical-care-ag-co-kgaa-nysefms-upgraded-by-stocknewscom-to-strong-buy-image

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Upgraded by StockNews.com to โ€œStrong-Buyโ€

Source from : Defense World - 4 days ago

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS โ€“ Get Rating) was upgraded by stock analysts at StockNews.com from a โ€œbuyโ€ rating to a โ€œstrong-buyโ€ rating in a research note issued to investors on ...See details»


Fresenius Medical Care AG & Co. KGaA

Source from : dgap - 5 days ago

Fresenius Medical Care AG & Co. KGaA: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution Fresenius Medical Care AG & Co.See details»


Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Given Consensus Rating of โ€œHoldโ€ by Analysts

Source from : ETF Daily News - 6 days ago

JPMorgan Chase & Co. raised their price objective on Fresenius Medical Care AG & Co. KGaA from โ‚ฌ48.70 ($51.81) to โ‚ฌ51.00 ($54.26) and gave the company an โ€œunderweightโ€ rating in a report ...See details»


Fresenius Medical Care AG & Co. KGaA: Supreme Court Ruling Raises Uncertainty for DaVita and Fresenius

Source from : YAHOO!Finance - 13 days ago

Find the latest Fresenius Medical Care AG (FMS) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance ...See details»


Here's Why You Should Retain Fresenius Medical (FMS) Stock Now

Source from : Nasdaq - 21 days ago

Fresenius Medical Care AG & Co. KGaA FMS is well-poised for growth on the back of a broad range of dialysis products and services and a solid global foothold. However, stiff competition remains a ...See details»


Global Critical Care Equipment Market to Reach $16.8 Billion by 2026

Source from : WFMZ-TV - 8 days ago

Companies: 49 - Players covered include AKAS Medical; B. Braun Melsungen AG; BPL Medical Technologies Pvt., Ltd.; Dragerwerk AG & Co. KGaA; Fresenius Kabi AG; General ...See details»


Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Upgraded by StockNews.com to โ€œStrong-Buyโ€

Source from : ETF Daily News - 4 days ago

Shares of Fresenius Medical Care AG & Co. KGaA stock opened at $24.94 on Friday. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.26 and a quick ratio of 0.93. Fresenius ...See details»


Fresenius Medical Care AG & Co. KGaA

Source from : dgap - 6 days ago

Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).See details»


Here's Why You Should Retain Fresenius Medical (FMS) Stock Now

Source from : Yahoo Finance - 21 days ago

Fresenius Medical Care AG & Co. KGaA FMS is well-poised for growth on the back of a broad range of dialysis products and services and a solid global foothold. However, stiff competition remains a ...See details»


Fresenius Medical Care AG & Co. KGaA

Source from : Wall Street Journal - 6 days ago

Lundbeck A/S, Dentsply Sirona, Inc. A. Gregory Sorensen Member-Supervisory Board Fresenius Medical Care AG & Co. KGaA, Empresa de Servicios Sanitarios de Los Lagos SA, IMRIS, Inc., Fusion ...See details»


Here's Why You Should Retain Fresenius Medical (FMS) Stock Now

Source from : Yahoo Movies UK - 21 days ago

Fresenius Medical Care AG & Co. KGaA FMS is well-poised for growth on the back of a broad range of dialysis products and services and a solid global foothold. However, stiff competition remains a ...See details»


Fresenius Medical Care AG & Co. KGaA - Stock Quote 0H9X

Source from : Morningstar%2c Inc. - 4 days ago

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...See details»